Deng Qichen, van 't Hul Alex, van Hees Hieronymus, Djamin Remco, Vaes Anouk W, Spruit Martijn A
Department of Research and Development, Ciro, Horn, The Netherlands.
Department of Respiratory Medicine, School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Sci Rep. 2025 Jul 22;15(1):26592. doi: 10.1038/s41598-025-08614-x.
Physical activity (PA) is a well-established prognostic marker in Chronic Obstructive Pulmonary Disease (COPD). Traditional PA metrics, such as step count, often overlook movement intensity, while energy expenditure (EE) relies on indirect calorimetry assumptions. To address these limitations, we propose a data-driven PA metric that integrates movement frequency and amplitude derived from raw accelerometer data. This retrospective analysis, based on a Dutch COPD database, also evaluates the predictive value of the new score for mortality in COPD patients compared to step count and energy expenditure. Movement data and step counts were collected using McRoberts triaxial accelerometers. Fourier analysis was applied to extract movement frequency and amplitude, which were then used to compute the physical activity (PA) score. Kolmogorov-Smirnov test was conducted to assess whether the distributions of step count and PA score differed, followed by Kruskal-Wallis test to assess day-to-day movement variability. Logistic regression was used to evaluate and compare the predictive performance of the novel PA score against step count and EE. A total of 404 COPD patients (51.5% female; median [IQR] age: 57 [46-66] years) were included. The proposed PA score and step count exhibited similar daily patterns but differed significantly in distribution. Mortality data were available for 165 participants. The PA score achieved 2.8% higher accuracy and 5.6% higher balanced accuracy than step count in mortality prediction, while EE demonstrated the lowest predictive performance. The proposed PA score demonstrates stronger predictive power for mortality in COPD patients, highlighting the importance of integrating movement characteristics beyond simple step count, and offering a more refined metric for PA evaluation in both clinical and research settings.
身体活动(PA)是慢性阻塞性肺疾病(COPD)中一个已被充分证实的预后指标。传统的PA指标,如步数,往往忽略了运动强度,而能量消耗(EE)则依赖于间接量热法假设。为了解决这些局限性,我们提出了一种数据驱动的PA指标,该指标整合了从原始加速度计数据中得出的运动频率和幅度。这项基于荷兰COPD数据库的回顾性分析,还评估了与步数和能量消耗相比,新评分对COPD患者死亡率的预测价值。使用麦克罗伯茨三轴加速度计收集运动数据和步数。应用傅里叶分析提取运动频率和幅度,然后用于计算身体活动(PA)评分。进行柯尔莫哥洛夫-斯米尔诺夫检验以评估步数和PA评分的分布是否不同,随后进行克鲁斯卡尔-沃利斯检验以评估每日运动变异性。使用逻辑回归来评估和比较新PA评分与步数和EE的预测性能。总共纳入了404例COPD患者(51.5%为女性;年龄中位数[四分位间距]:57[46 - 66]岁)。所提出的PA评分和步数呈现出相似的每日模式,但分布有显著差异。有165名参与者的死亡率数据可用。在死亡率预测方面,PA评分比步数的准确率高2.8%,平衡准确率高5.6%,而EE的预测性能最低。所提出的PA评分对COPD患者的死亡率显示出更强的预测能力,突出了整合简单步数之外的运动特征的重要性,并为临床和研究环境中的PA评估提供了一个更精细的指标。